Purchase Order W81XWH21P0024
Award Date 1/12/21
Potential Completion Date 12/11/21
Potential Value $250K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- This is a $1,264,126.01 firm-fixed-price definitive contract awarded by the Defense Health Agency (DHA) to Green Mountain Antibodies Inc. for research and development services related to developing monoclonal antibodies against the ESKAPEE pathogens. The contract has a base period of performance from September 30, 2020 to September 29, 2021, with four one-year option periods extending the potential completion date to September 29, 2025. This contract was awarded on a sole-source basis to a small...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command to Biofactura Inc., a for-profit manufacturer, to develop a process for producing an antibody-based therapy against the Marburg virus. The contract has a firm fixed price of $149,528.62 and a completion date of January 15, 2019. The contract is set aside for a small business. This SBIR Phase I award is part of the Army's efforts to advance medical countermeasures against...
- This is a $149,543.35 Firm Fixed Price contract awarded by the U.S. Army Medical Command (MEDCOM) to Biological Mimetics, Inc., a small business, under the Small Business Innovation Research (SBIR) program. The contract is for a Phase I SBIR project to develop a CRISPR-based diagnostic test for parasites. The contract has a period of performance through August 30, 2016. Biological Mimetics is a biotechnology firm that provides research, development, and testing services related to infectious...
- <p>This is a federal contract award from the U.S. Army Medical Command (MEDCOM) to Technovax Inc., a minority-owned, small disadvantaged business. The contract, valued at $149,999.96, is for a Phase I Small Business Innovation Research (SBIR) project under Solicitation A151-051-0493. The contract is a definitive, firm-fixed-price contract with a completion date of September 30, 2016. The contract is set aside for small businesses.</p>
- This definitive contract from the Department of Health and Human Services' National Institutes of Health and National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) is valued at $600,000 to Qoolabs Inc. for monoclonal antibodies research aligned with SBIR Topic 107. The solicitation sought Small Business Innovation Research (SBIR) proposals across technical topics within NIH Institutes and CDC Centers to develop medical technologies, diagnostics, vaccines, cell therapies and...
- This is a $2,574,853.28 Firm Fixed Price contract awarded by the Department of the Army Medical Command to Technovax Inc., a Minority Owned, Self Certified Small Disadvantaged Business, for the "Next-Generation Adenovirus Vaccine" under the ARMY 15.1 SBIR (Small Business Innovation Research) program. The contract is set aside for Small Businesses and has a period of performance through March 31, 2023. The contract is associated with the National Interest Action Code for the Coronavirus...
- The Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $599,980 firm fixed price contract to Tendel Therapies, Inc., a small business, for research and development services related to genetic adjuvants to promote durable anti-influenza stem antibodies in older adults. This contract was awarded under the NIH and Centers for Disease Control and Prevention's Small Business Innovation Research (SBIR) program,...
- This is a $450,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) to Versatope Therapeutics Inc., a for-profit biotechnology company. The contract is for the development of a novel adjuvant for a malaria vaccine, using Versatope's recombinant outer membrane vesicle (ROMV) technology. The original solicitation was part of the NIH and Centers for Disease Control and Prevention (CDC) SBIR Program, which seeks to stimulate...
- This is a $300,000.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Kephera Diagnostics LLC, a small business, for the discovery and validation of novel diagnostic biomarkers for malaria and select neglected tropical diseases. The contract is a Small Business Innovation Research (SBIR) Phase I award, meaning it supports early-stage research and development efforts. The work will be performed in Framingham,...
- This federal contract award, valued at $149,964.61, was made by the Joint Program Executive Office for Chemical and Biological Defense, a U.S. Department of Defense organization, to Abzyme Therapeutics LLC, a small, minority-owned, for-profit limited liability company. The contract was awarded under the Small Business Innovation Research (SBIR) program, Phase I, and is a firm-fixed-price purchase order. The contract supports research and development work by Abzyme Therapeutics related to...